277 related articles for article (PubMed ID: 23625834)
1. Bioreactor design for clinical-grade expansion of stem cells.
dos Santos FF; Andrade PZ; da Silva CL; Cabral JM
Biotechnol J; 2013 Jun; 8(6):644-54. PubMed ID: 23625834
[TBL] [Abstract][Full Text] [Related]
2. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors.
Krawetz R; Taiani JT; Liu S; Meng G; Li X; Kallos MS; Rancourt DE
Tissue Eng Part C Methods; 2010 Aug; 16(4):573-82. PubMed ID: 19737071
[TBL] [Abstract][Full Text] [Related]
3. Scalable microcarrier-based manufacturing of mesenchymal stem/stromal cells.
de Soure AM; Fernandes-Platzgummer A; da Silva CL; Cabral JM
J Biotechnol; 2016 Oct; 236():88-109. PubMed ID: 27527397
[TBL] [Abstract][Full Text] [Related]
4. Scalable ex vivo expansion of human mesenchymal stem/stromal cells in microcarrier-based stirred culture systems.
Carmelo JG; Fernandes-Platzgummer A; Cabral JM; da Silva CL
Methods Mol Biol; 2015; 1283():147-59. PubMed ID: 25063496
[TBL] [Abstract][Full Text] [Related]
5. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
Abbasalizadeh S; Baharvand H
Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
[TBL] [Abstract][Full Text] [Related]
6. Stem cell cultivation in bioreactors.
Rodrigues CA; Fernandes TG; Diogo MM; da Silva CL; Cabral JM
Biotechnol Adv; 2011; 29(6):815-29. PubMed ID: 21726624
[TBL] [Abstract][Full Text] [Related]
7. Good manufacturing practices production of mesenchymal stem/stromal cells.
Sensebé L; Bourin P; Tarte K
Hum Gene Ther; 2011 Jan; 22(1):19-26. PubMed ID: 21028982
[TBL] [Abstract][Full Text] [Related]
8. Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology.
Eibl R; Kaiser S; Lombriser R; Eibl D
Appl Microbiol Biotechnol; 2010 Mar; 86(1):41-9. PubMed ID: 20094714
[TBL] [Abstract][Full Text] [Related]
9. Scalable Expansion of Pluripotent Stem Cells.
Lavon N; Zimerman M; Itskovitz-Eldor J
Adv Biochem Eng Biotechnol; 2018; 163():23-37. PubMed ID: 29085956
[TBL] [Abstract][Full Text] [Related]
10. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
[TBL] [Abstract][Full Text] [Related]
11. Bioreactor expansion of human mesenchymal stem cells according to GMP requirements.
Elseberg CL; Salzig D; Czermak P
Methods Mol Biol; 2015; 1283():199-218. PubMed ID: 25540116
[TBL] [Abstract][Full Text] [Related]
12. Serum-free scaled up expansion and differentiation of murine embryonic stem cells to osteoblasts in suspension bioreactors.
Alfred R; Gareau T; Krawetz R; Rancourt D; Kallos MS
Biotechnol Bioeng; 2010 Aug; 106(5):829-40. PubMed ID: 20564618
[TBL] [Abstract][Full Text] [Related]
13. Cellular manufacturing for clinical applications.
Sheu J; Klassen H; Bauer G
Dev Ophthalmol; 2014; 53():178-88. PubMed ID: 24732771
[TBL] [Abstract][Full Text] [Related]
14. Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?
Rousseau GF; Giarratana MC; Douay L
Biotechnol J; 2014 Jan; 9(1):28-38. PubMed ID: 24408610
[TBL] [Abstract][Full Text] [Related]
15. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor.
Nold P; Brendel C; Neubauer A; Bein G; Hackstein H
Biochem Biophys Res Commun; 2013 Jan; 430(1):325-30. PubMed ID: 23146633
[TBL] [Abstract][Full Text] [Related]
16. Manufacturing and banking of mesenchymal stem cells.
Thirumala S; Goebel WS; Woods EJ
Expert Opin Biol Ther; 2013 May; 13(5):673-91. PubMed ID: 23339745
[TBL] [Abstract][Full Text] [Related]
17. Large-scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors.
Youn BS; Sen A; Kallos MS; Behie LA; Girgis-Gabardo A; Kurpios N; Barcelon M; Hassell JA
Biotechnol Prog; 2005; 21(3):984-93. PubMed ID: 15932284
[TBL] [Abstract][Full Text] [Related]
18. Robust, quantitative tools for modelling ex-vivo expansion of haematopoietic stem cells and progenitors.
Winkler DA; Burden FR
Mol Biosyst; 2012 Mar; 8(3):913-20. PubMed ID: 22282302
[TBL] [Abstract][Full Text] [Related]
19. Engineering stem cell fate with biochemical and biomechanical properties of microcarriers.
Sart S; Agathos SN; Li Y
Biotechnol Prog; 2013; 29(6):1354-66. PubMed ID: 24124017
[TBL] [Abstract][Full Text] [Related]
20. Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013.
Wang Y; Cheng L; Gerecht S
Ann Biomed Eng; 2014 Jul; 42(7):1357-72. PubMed ID: 24132657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
